Chicago, IL 的 鐮狀細胞病 臨床試驗
18 項針對 鐮狀細胞病 的研究正在 Chicago（約 30 英里範圍內）及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本（英文）
正在為研究招募對象嗎？將此頁面置頂展示 — $99 / 30 天 →
A Phase 1b, Open-Label Study of DISC-3405 in Participants With Sickle Cell Disease (SCD)
招募中1 期
- University of Illinois Hospital and Health Sciences System, Chicago
A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
招募中1 期
- University of Illinois at Chicago College of Medicine, Chicago
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
招募中3 期
- Uni of Illinois Hospital and HSC, Chicago
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
招募中3 期
- Univer Of Illinois at Chicago, Chicago
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
招募中3 期
- Childrens Hospital of Chicago, Chicago
- Univer Of Illinois at Chicago, Chicago
Tocilizumab for Acute Chest Syndrome
招募中2 期
- University of Chicago, Chicago
A Phase 2/3 Study of Osivelotor in Adult and Adolescent Participants With SCD
招募中2/3 期
- University of Illinois at Chicago Clinical Research Center, Chicago
- University of Illinois Hospital and Health Sciences System - Investigational Drug Services (IDS), Chicago
- University of Illinois Hospital and Health Sciences System, Chicago
A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
招募中1/2 期歡迎健康志工
- Local Institution - 0034, Chicago
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
招募中觀察性研究
- Rush University Medical Center, Chicago
Safety, Efficacy, and Pharmacokinetics of CSL889 in Adults and Adolescents With Sickle Cell Disease During Vaso-Occlusive Crisis
招募中2 期
- University of Illinois at Chicago, Chicago
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
招募中3 期
- University of Illinois-Chicago - College of Medicine- Site Number : 8400054, Chicago
Study of HLA-Haploidentical Stem Cell Transplantation to Treat Clinically Aggressive Sickle Cell Disease
招募中2 期
- University of Illinois at Chicago, Chicago
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
招募中觀察性研究
- Comer Children's Hospital (MRD-HCT), Chicago
Targeting the Pathophysiology of Sickle Cell-Related Kidney Disease Using the SGLT2 Inhibitors, Empagliflozin
招募中2 期
- University of Illinois Chicago, Sickle Cell Center, Chicago
Delivering Patient-Facing Evidence-Based Guidelines Through mHealth to Adults With Sickle Cell Disease
招募中
- University of Illinois at Chicago, Chicago
Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease
招募中2 期
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
Peer Support for Adolescents and Emerging Adults With Sickle Cell Pain
招募中
- Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
招募中觀察性研究
- University of Illinois, Chicago
其他城市的 鐮狀細胞病 試驗
- Atlanta, GA22 項研究
- Washington, DC20 項研究
- Memphis, TN18 項研究
- Philadelphia, PA15 項研究
- Birmingham, AL14 項研究
- New York City, NY13 項研究
- St. Louis, MO12 項研究
- Boston, MA10 項研究
- Durham, NC10 項研究
- Houston, TX10 項研究
- Cincinnati, OH10 項研究
- Greenville, NC9 項研究
Chicago 的其他研究
- 非小細胞肺癌61 項研究
- 乳癌59 項研究
- 癌症（所有類型）51 項研究
- 轉移性癌症45 項研究
- 前列腺癌45 項研究
- 肺癌41 項研究
- 肥胖症41 項研究
- 卵巢癌36 項研究
- 大腸直腸癌34 項研究
- 中風34 項研究
- 心臟衰竭31 項研究
- 過重29 項研究
資料來源：ClinicalTrials.gov，擷取日期 2026年10月6日。各研究自行設定資格標準；由研究團隊決定參與者資格。